Bulldozing chromatin to make way for CRISPR

MilliporeSigma is ready to license its CRISPR system that uses two Cas9 proteins

MilliporeSigma is patenting a dual-Cas9 system that opens previously inaccessible genomic sites and edits genes, even highly homologous ones, with greater specificity than other CRISPR systems.

Gregory Davis, head of genome editing R&D at MilliporeSigma, told BioCentury that

Read the full 376 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE